Akari Therapeutics, Plc (AKTX) Insider Trading Activity

NASDAQ$9.08+0.93 (11.41%)
Market Cap
$18.71M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
396 of 849
Rank in Industry
233 of 491

AKTX Insider Trading Activity

AKTX Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
–
Sells
$0
0
–

Related Transactions

About Akari Therapeutics, Plc

Akari Therapeutics, Plc, an oncology company, develops antibody-drug conjugates (ADC) for cancer-killing toxins. Its lead payload is PH1 to disrupt the function of spliceosomes and to trigger an immune response that leads to additional cancer cell killing. The company’s lead product candidate is AKTX-101, a preclinical stage trop2-targeting ADC that combines PH1 with the trop2 antibody to treat solid tumor cancer types, including lung, breast, bladder, head and neck, gastric, pancreatic, colon, prostate, and others. Its payloads include PH1 is …

Insider Activity of Akari Therapeutics, Plc

Over the last 12 months, insiders at Akari Therapeutics, Plc have bought $0 and sold $0 worth of Akari Therapeutics, Plc stock.

On average, over the past 5 years, insiders at Akari Therapeutics, Plc have bought $56,660 and sold $0 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 3,000 shares for transaction amount of $2,700 was made by Gaslightwala Abizer (CEO) on 2025‑08‑25.

List of Insider Buy and Sell Transactions, Akari Therapeutics, Plc

2025-08-25PurchaseGaslightwala AbizerCEO
3,000
17.9677%
$0.90
$2,700
-69.77%
2025-08-22PurchaseGaslightwala AbizerCEO
8,000
49.5109%
$0.93
$7,440
-70.88%
2025-08-21PurchaseGaslightwala AbizerCEO
10,000
62.326%
$0.94
$9,400
-70.97%
2025-06-24PurchaseGaslightwala AbizerPresident & CEO
5,203
32.341%
$1.16
$6,035
-68.06%
2025-06-23PurchaseGaslightwala AbizerPresident & CEO
943
5.811%
$1.15
$1,084
-67.69%
2025-06-20PurchaseGaslightwala AbizerPresident & CEO
10,000
66.5964%
$1.20
$12,000
-66.44%
2025-06-17PurchaseGaslightwala AbizerPresident & CEO
15,000
94.8167%
$1.20
$18,000
-67.80%
2015-09-18PurchaseCohen Mark Sdirector
1.06M
0.0711%
$0.19
$200,036
-56.12%
2014-04-15PurchaseSABBY MANAGEMENT, LLC10 percent owner
17,100
0.3007%
$5.00
$85,500
+9.59%
2014-04-14PurchaseSABBY MANAGEMENT, LLC10 percent owner
3,000
0.0539%
$5.21
$15,630
+7.49%
2014-04-11PurchaseSABBY MANAGEMENT, LLC10 percent owner
100
0.0017%
$5.15
$515
+3.70%
2014-04-10PurchaseSABBY MANAGEMENT, LLC10 percent owner
1,400
0.0252%
$5.25
$7,350
+6.67%
2014-04-09PurchaseSABBY MANAGEMENT, LLC10 percent owner
1,075
0.0194%
$5.51
$5,923
+1.82%
2014-04-08PurchaseSABBY MANAGEMENT, LLC10 percent owner
35,500
0.6218%
$5.36
$190,280
+1.82%
2014-04-07PurchaseSABBY MANAGEMENT, LLC10 percent owner
20,654
0.3716%
$5.71
$117,840
-1.75%
2014-04-04PurchaseSABBY MANAGEMENT, LLC10 percent owner
12,250
0.216%
$6.07
$74,400
-9.52%
2014-04-02PurchaseSABBY MANAGEMENT, LLC10 percent owner
2,500
0.0441%
$6.15
$15,375
-10.45%
2014-04-01PurchaseSABBY MANAGEMENT, LLC10 percent owner
15,371
0.2742%
$6.10
$93,806
-8.46%
2014-03-31PurchaseSABBY MANAGEMENT, LLC10 percent owner
7,936
0.1396%
$6.35
$50,394
-13.10%
2014-03-27PurchaseSABBY MANAGEMENT, LLC10 percent owner
1,700
0.0344%
$6.61
$11,237
-14.50%
Total: 26

Insider Historical Profitability

<0.0001%
Cohen Mark Sdirector
1055600
45.9779%
$8.6M10
SABBY MANAGEMENT, LLC10 percent owner
778030
33.888%
$6.34M180
Gaslightwala AbizerCEO
298574
13.0047%
$2.43M70
<0.0001%

Historical Insider Profitability vs. Competitors

$931,435
28
16.31%
$24.8M
$226,127
22
-27.62%
$21.96M
$114,619,342
20
-7.41%
$16.39M
$352,389
18
9.66%
$17.82M
$742,412
14
-50.36%
$17.71M

AKTX Institutional Investors: Active Positions

Increased Positions12+63.16%3M+287.04%
Decreased Positions6-31.58%75,741-6.47%
New Positions9New3MNew
Sold Out Positions4Sold Out70,739Sold Out
Total Postitions25+31.58%4M+280.56%

AKTX Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Cresset Asset Management, Llc$239.00<0.01%822,468+804,060+4,367.99%2025-09-30
Palo Alto Investors Lp$42.000%146,02400%2025-09-30
Hightower Advisors, Llc$23.000%79,23600%2025-09-30
Omnia Family Wealth, Llc$8.000%28,440-34,250-54.63%2025-09-30
Cerity Partners Llc$7.000%23,64300%2025-09-30
Virtu Financial Llc$7.000%22,502+22,502New2025-09-30
Two Sigma Securities, Llc$6.000%19,753+19,753New2025-09-30
Independent Advisor Alliance$3.000%10,887+10,887New2025-09-30
Accent Capital Management, Llc$3.000%10,00000%2025-09-30
Newedge Advisors, Llc$2.000%6,80000%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.